Advertisement

Biocon CMD News

alt
India may have created a competitive market by abolishing licence raj, but it has been replaced by an equally time-consuming "approval raj" fraught with potential corruption, Biocon CMD Kiran Mazumdar-Shaw has said.
alt
During the quarter, Biocon reported exceptional gain of Rs 105.06 crore on account of share sale in its research services subsidiary Syngene.






Loading...
english news
NEWS ON ONE CLICK